AI|ffinity
Brno
About AI|ffinity
AI|ffinity leverages NMR, AI, and Cheminformatics to provide innovative solutions to the pharmaceutical and biotech sectors, our comprehensive NMR-AI platform covering the entire Target-to-Lead process, and our 4D NMR-AI technology with applications in drug design and protein engineering. Integrating drug design technology with NMR, the goal is to expedite the initial phases of drug discovery, enhance success rates, and cut costs by circumventing unneeded experiments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $443.8K
- Funding stage: Seed
- Last round: Seed (Nov 2024)
- Website: aiffinity.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/ai-ffinity-8806 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.